Cogent Biosciences (COGT) Preferred Shares (2020 - 2026)
Cogent Biosciences (COGT) posted quarterly Preferred Shares of $35.6 million for Q1 2026, down 34.24% year-over-year from $54.1 million in Q1 2025, and down 33.93% quarter-over-quarter from $53.8 million in Q4 2025.
Cogent Biosciences (COGT) Preferred Shares (2020 - 2026) Analysis & Trends
Cogent Biosciences (COGT) has reported Preferred Shares for 7 consecutive years, with $35.6 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Preferred Shares fell 34.24% year-over-year to $35.6 million; the TTM figure through Mar 2026 stood at $35.6 million (down 34.24% YoY), while the FY2025 annual figure was $53.8 million, changed 0.47% from the prior year.
- Preferred Shares eased to $35.6 million in Q1 2026 per COGT's latest filing, from $53.8 million in the prior quarter.
- Across five years, Preferred Shares topped out at $162.1 million in Q1 2024 and bottomed at $35.6 million in Q1 2026.
- Historically, Preferred Shares has averaged $65.2 million across 5 years, with a median of $60.0 million in 2023.
- Annual changes were most pronounced in 2024 — Preferred Shares surged 160.18% — and 2025, when it slumped 66.64%.
- Cogent Biosciences' Preferred Shares stood at $65.8 million in 2022, then dropped by 8.8% to $60.0 million in 2023, then fell by 9.91% to $54.1 million in 2024, then declined by 0.47% to $53.8 million in 2025, then plunged by 33.93% to $35.6 million in 2026.
- Business Quant data shows COGT's Preferred Shares at $35.6 million in Q1 2026, $53.8 million in Q4 2025, and $53.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Cogent Biosciences | 6.58 Bn | 6.58 Bn | - | 35.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 35.56 Mn |
| Mar 31, 2026 | 35.56 Mn |
| Dec 31, 2025 | 53.83 Mn |
| Sep 30, 2025 | 53.83 Mn |
| Jun 30, 2025 | 53.83 Mn |
| Mar 31, 2025 | 54.08 Mn |
| Dec 31, 2024 | 54.09 Mn |
| Sep 30, 2024 | 54.09 Mn |
| Jun 30, 2024 | 60.04 Mn |
| Mar 31, 2024 | 162.12 Mn |
| Dec 31, 2023 | 60.04 Mn |
| Sep 30, 2023 | 60.04 Mn |
| Jun 30, 2023 | 62.31 Mn |
| Mar 31, 2023 | 62.31 Mn |
| Dec 31, 2022 | 65.83 Mn |
| Sep 30, 2022 | 65.83 Mn |
| Jun 30, 2022 | 71.40 Mn |
| Mar 31, 2022 | 78.40 Mn |
| Dec 31, 2021 | 85.40 Mn |
| Dec 31, 2020 | 110.88 Mn |